78 related articles for article (PubMed ID: 21453382)
1. Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma.
Akagi I; Miyashita M; Ishibashi O; Mishima T; Kikuchi K; Makino H; Nomura T; Hagiwara N; Uchida E; Takizawa T
Dis Esophagus; 2011 Sep; 24(7):523-30. PubMed ID: 21453382
[TBL] [Abstract][Full Text] [Related]
2. RNASEN regulates cell proliferation and affects survival in esophageal cancer patients.
Sugito N; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Kurehara H; Ando T; Mori R; Takashima N; Ogawa R; Fujii Y
Clin Cancer Res; 2006 Dec; 12(24):7322-8. PubMed ID: 17121874
[TBL] [Abstract][Full Text] [Related]
3. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma.
Sun L; Dong S; Dong C; Sun K; Meng W; Lv P; Yin H; Ming L; He F
Cancer Biomark; 2016; 16(2):265-73. PubMed ID: 26756617
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.
Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H
Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059
[TBL] [Abstract][Full Text] [Related]
7. Altered miRNA expression is associated with differentiation, invasion, and metastasis of esophageal squamous cell carcinoma (ESCC) in patients from Huaian, China.
Fu HL; Wu DP; Wang XF; Wang JG; Jiao F; Song LL; Xie H; Wen XY; Shan HS; Du YX; Zhao YP
Cell Biochem Biophys; 2013 Nov; 67(2):657-68. PubMed ID: 23516093
[TBL] [Abstract][Full Text] [Related]
8. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
9. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma.
Yang M; Liu R; Sheng J; Liao J; Wang Y; Pan E; Guo W; Pu Y; Yin L
Oncol Rep; 2013 Jan; 29(1):169-76. PubMed ID: 23124769
[TBL] [Abstract][Full Text] [Related]
10. Different expression of miRNAs in early esophageal squamous cell carcinoma with differential prognosis.
Lu J; Lu N; Xue L; Jin M
Dis Esophagus; 2015; 28(4):386-93. PubMed ID: 24697845
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Tiam1 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Liu H; Shi G; Liu X; Wu H; Fan Q; Wang X
Oncol Rep; 2011 Mar; 25(3):841-8. PubMed ID: 21186404
[TBL] [Abstract][Full Text] [Related]
12. An integrated analysis of the effects of microRNA and mRNA on esophageal squamous cell carcinoma.
Yang Y; Li D; Yang Y; Jiang G
Mol Med Rep; 2015 Jul; 12(1):945-52. PubMed ID: 25823933
[TBL] [Abstract][Full Text] [Related]
13. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
Faried A; Faried LS; Usman N; Kato H; Kuwano H
Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma.
Kurashige J; Kamohara H; Watanabe M; Tanaka Y; Kinoshita K; Saito S; Hiyoshi Y; Iwatsuki M; Baba Y; Baba H
J Surg Oncol; 2012 Aug; 106(2):188-92. PubMed ID: 22354855
[TBL] [Abstract][Full Text] [Related]
16. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of MCM4 in esophageal cancer].
Huang XP; Zhang X; Su XD; Ma GW; Zhao JM; Rong TH
Ai Zheng; 2007 Jan; 26(1):96-9. PubMed ID: 17222376
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for the sensitivity of radiotherapy and prognosis of esophageal squamous cell carcinoma.
Wu S; Wang X; Chen JX; Chen Y
Int J Radiat Biol; 2014 May; 90(5):407-13. PubMed ID: 24576011
[TBL] [Abstract][Full Text] [Related]
19. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of early esophageal squamous cell carcinoma by cDNA microarray.
Zhang X; Lin P; Zhu ZH; Long H; Wen J; Yang H; Zhang X; Wang DF; Fu JH; Fang Y; Rong TH
Cancer Genet Cytogenet; 2009 Oct; 194(1):23-9. PubMed ID: 19737650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
